Heparin-Induced Thrombocytopenia in Patients Suffering Cardiogenic Shock.

ABSTRACT:

Objectives

Cardiogenic shock (CS) is associated with high mortality. Patients treated for CS mostly require heparin therapy, which may be associated with complications such as heparin-induced thrombocytopenia (HIT). HIT represents a serious condition associated with platelet decline and increased hypercoagulability and remains a poorly researched field in intensive care medicine. Primary purpose of this study was to: 1) determine HIT prevalence in CS, 2) assess the performance of common diagnostic tests for the workup of HIT, and 3) compare outcomes in CS patients with excluded and confirmed HIT.

Design

Retrospective dual-center study including adult patients 18 years old or older with diagnosed CS and suspected HIT from January 2010 to November 2022.

Setting

Cardiac

SUBMITTER: Lusebrink E 

PROVIDER: S-EPMC11265775 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature